AIRNA

A bold vision for genetic medicines

Cambridge, United States · Founded 2021 · $245.0M raised

Employees
11–50
Founded
2021
Business Model
B2B
Website
airna.com
Total Funding
$245.0M
Last Round
$155.0M Series BApr 2025
Rounds
3

About

AIRNA is a clinical-stage biotechnology company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases. Founded in 2021 and headquartered in Cambridge, Massachusetts, with research operations in Tübingen, Germany, AIRNA harnesses the body's natural RNA-editing machinery to develop precision medicines. The company's lead program AIR-001 targets alpha-1 antitrypsin deficiency (AATD).

Summary

AIRNA is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $245.0M in total across 3 rounds, most recently a $155.0M Series B round in Apr 2025. Investors include Forbion Capital Partners, Venrock and ARCH Venture Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BApr 2025
$155.0M

Sign up to see all 3 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AIRNA on Indexed.vc
<a href="https://indexed.vc/companies/airna"><img src="https://indexed.vc/api/badge/company/airna" alt="AIRNA on Indexed.vc" width="260" height="76" /></a>